We are excited to announce our participation in the upcoming Precision Medicine World Conference (PMWC), the foremost gathering of leaders, researchers, and innovators in healthcare and biotechnology.

PMWC is renowned for showcasing the latest practical content, promoting cross-functional collaboration, and accelerating advancements in precision medicine.

We will discuss the impact of 3D pathology on precision analysis. Recent advancements in non-destructive 3D pathology, such as our Hybrid-open-top light-sheet microscopy, enable comprehensive imaging of large clinical specimens, providing detailed insights into tissue architecture and disease mechanisms. These technologies facilitate more accurate diagnoses and personalized treatment plans by preserving the spatial context of tissues.

Moreover, integrating artificial intelligence with 3D pathology has led to the development of platforms like Tripath (https://www.cell.com/cell/abstract/S0092-8674(24)00351-9), which process 3D tissue data to predict patient outcomes based on morphological features. Studies have shown that cancer recurrence models trained on 3D tissue volumes outperform those trained on traditional 2D images, highlighting the potential of 3D pathology in enhancing precision medicine.

If you are attending PMWC and would like to explore this topic further, please contact us to arrange a meeting with our CEO, Nick Reder, MD, MPH.

We look forward to connecting with fellow professionals and advancing the future of personalized healthcare together.